One species, different diseases: the unique molecular mechanisms that underlie the pathogenesis of typhoidal Salmonella infections
Highlights•Salmonella enterica is comprised of non-typhoidal and typhoidal
serovars.•Typhoidal Salmonella causes enteric fever instead of self-limiting …
serovars.•Typhoidal Salmonella causes enteric fever instead of self-limiting …
Typhoid fever control in the 21st century: where are we now?
Typhoid fever control in the 21st century: where are we now? : Current Opinion in Infectious
Diseases Typhoid fever control in the 21st century: where are we now? : Current Opinion in …
Diseases Typhoid fever control in the 21st century: where are we now? : Current Opinion in …
Burden of typhoid and paratyphoid fever in India
J John, A Bavdekar… - … England Journal of …, 2023 - Mass Medical Soc
Background In 2017, more than half the cases of typhoid fever worldwide were projected to
have occurred in India. In the absence of contemporary population-based data, it is unclear …
have occurred in India. In the absence of contemporary population-based data, it is unclear …
[HTML][HTML] Typhoid fever surveillance, incidence estimates, and progress toward typhoid conjugate vaccine introduction—worldwide, 2018–2022
M Hancuh - MMWR. Morbidity and mortality weekly report, 2023 - cdc.gov
Typhoid Fever Surveillance, Incidence Estimates, and Progress Toward Typhoid Conjugate
Vaccine Introduction — Worldwide, 2018–2022 | MMWR Skip directly to site content Skip …
Vaccine Introduction — Worldwide, 2018–2022 | MMWR Skip directly to site content Skip …
Estimating typhoid incidence from community-based serosurveys: a multicohort study
Background The incidence of enteric fever, an invasive bacterial infection caused by
typhoidal Salmonellae (Salmonella enterica serovars Typhi and Paratyphi), is largely …
typhoidal Salmonellae (Salmonella enterica serovars Typhi and Paratyphi), is largely …
Therapeutic Potential of Pectin and Its Derivatives in Chronic Diseases
Non-communicable diseases (NCDs) are described as a collection of chronic diseases that
do not typically develop from an acute infection, have long-term health effects, and …
do not typically develop from an acute infection, have long-term health effects, and …
Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990–2019: a …
AJ Browne, MG Chipeta, FJ Fell… - The Lancet Global …, 2024 - thelancet.com
Background Enteric fever, a systemic infection caused by Salmonella enterica serovars
Typhi and Paratyphi A, remains a major cause of morbidity and mortality in low-income and …
Typhi and Paratyphi A, remains a major cause of morbidity and mortality in low-income and …
Incidence of typhoid fever in Burkina Faso, Democratic Republic of the Congo, Ethiopia, Ghana, Madagascar, and Nigeria (the Severe Typhoid in Africa programme) …
F Marks, J Im, SE Park, GD Pak, HJ Jeon… - The Lancet Global …, 2024 - thelancet.com
Summary Background Typhoid Fever remains a major cause of morbidity and mortality in
low-income settings. The Severe Typhoid in Africa programme was designed to address …
low-income settings. The Severe Typhoid in Africa programme was designed to address …
5-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomised trial
Background WHO currently recommends a single dose of typhoid conjugate vaccine (TCV)
in high-burden countries based on 2-year vaccine efficacy data from large randomised …
in high-burden countries based on 2-year vaccine efficacy data from large randomised …
Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3, randomised controlled trial in Malawian children
Background Randomised controlled trials of typhoid conjugate vaccines among children in
Africa and Asia have shown high short-term efficacy. Data on the durability of protection …
Africa and Asia have shown high short-term efficacy. Data on the durability of protection …